Is it safe to prescribe Benztropine (anticholinergic medication) to a patient already taking Lorazepam (Ativan, benzodiazepine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benztropine and Lorazepam Co-Prescription

Yes, benztropine can be prescribed to a patient already taking lorazepam, but this combination requires careful consideration of additive anticholinergic and sedative effects, particularly in elderly or debilitated patients.

Clinical Context and Safety Considerations

The combination of benztropine (an anticholinergic agent) with lorazepam (a benzodiazepine) is not contraindicated, but requires awareness of potential additive effects:

Additive Sedation and Cognitive Effects

  • Both medications can cause sedation, confusion, and psychomotor impairment, which may be compounded when used together 1
  • Benztropine has been shown to induce deficits in attention and concentration in patients receiving chronic therapy 2
  • Lorazepam carries risks of drowsiness, dizziness, and paradoxical agitation, particularly when combined with other CNS depressants 1

Anticholinergic Burden

  • Benztropine is a potent antimuscarinic agent that can cause significant anticholinergic toxicity including delirium 3
  • When antipsychotics with anticholinergic properties are combined with anticholinergics like benztropine, there is increased risk of serious complications including ischemic colitis 4
  • The anticholinergic effects of benztropine may be particularly problematic in elderly patients who are already at higher risk for delirium 1

Dosing Adjustments When Co-Prescribing

If prescribing both medications together, use reduced doses of lorazepam:

  • Standard lorazepam dosing is 0.5-1 mg PRN (maximum 4 mg/24 hours) 1, 5
  • When co-administered with anticholinergics or in elderly/debilitated patients, reduce lorazepam to 0.25-0.5 mg 1
  • For elderly patients specifically, maximum daily lorazepam should not exceed 2 mg when combined with other CNS-active medications 1

Clinical Indications Where This Combination May Be Appropriate

  • Acute dystonic reactions: Benztropine is indicated for neuroleptic-induced acute dystonias, and lorazepam may be used concurrently for anxiety or agitation 1, 6
  • Delirium with agitation: Guidelines support adding benzodiazepines like lorazepam to antipsychotic regimens when patients remain agitated, though benztropine would typically only be added if extrapyramidal symptoms develop 1
  • Parkinson's disease with anxiety: Benztropine may be used for parkinsonian symptoms while lorazepam addresses anxiety, though this requires careful monitoring 7

Key Monitoring Parameters

  • Watch for excessive sedation, particularly in the first few days of combined therapy 1
  • Monitor for anticholinergic toxicity: dry mouth, urinary retention, constipation, confusion, and delirium 4, 3
  • Assess fall risk, especially in elderly patients, as both medications increase this risk 1, 5
  • Evaluate for paradoxical agitation, which can occur with either medication 1, 6

Important Caveats

  • Benztropine should only be prescribed if extrapyramidal symptoms are actually present, not prophylactically, as only 14.2% of patients develop symptoms severe enough to require treatment 2
  • Lorazepam should be prescribed for short-term use only (ideally maximum 4 weeks) to prevent tolerance and dependence 7
  • The combination should be avoided or used with extreme caution in patients with severe pulmonary insufficiency, severe liver disease, or myasthenia gravis 1
  • Consider diphenhydramine instead of benztropine for dystonic reactions if the patient is already on lorazepam and you want to minimize additive effects 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The withdrawal of benztropine mesylate in chronic schizophrenic patients.

The British journal of psychiatry : the journal of mental science, 1983

Guideline

Buspirone for Anxiety Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Use of benzodiazepines in psychiatry.

Therapia Hungarica (English edition), 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.